A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Clinical trial NCT04601766 · COMPLETED
Trial details
- NCT number
- NCT04601766
- Sponsor
- Asieris Pharmaceuticals (AUS) Pty Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2020-12-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.